A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
An Exploratory Study of HRD Score in Chinese Ovarian Cancer Patients Benefiting From PARP Inhibitor Targeted Therapy
- Status
- UNKNOWN
- Phase
- N/A
MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients.
- Status
- RECRUITING
- Phase
- PHASE3
(VELA) Study of BLU-222 in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
- Status
- RECRUITING
- Phase
- N/A
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
AOH1996 for the Treatment of Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Video Education With Result Dependent dIsclosure
- Status
- RECRUITING
- Phase
- NA
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
- Status
- RECRUITING
- Phase
- N/A
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
- Status
- COMPLETED
- Phase
- N/A
APX005M in Patients With Recurrent Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2